Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gerard J. Malnar"'
Autor:
Diane M Harper, Britney M Else, Mitchell J Bartley, Anne M Arey, Angela L Barnett, Beth E Rosemergey, Christopher A Paynter, Inge Verdenius, Sean M Harper, George D Harris, Jennifer A Groner, Gerard J Malnar, Jeffrey Wall, Aaron J Bonham
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e103172 (2014)
OBJECTIVES:Obesity adversely inhibits antibody response to vaccination. Three doses of HPV4 may or may not provide adequate long term protection against HPV 16/18 in obese females. The aim of this study was to determine whether adherence to HPV4 vacc
Externí odkaz:
https://doaj.org/article/07636110f92d4ba7a6125f106a74e414
Autor:
Kelly Jo Sandri, Inge Verdenius, Mitchell J Bartley, Britney M Else, Christopher A Paynter, Beth E Rosemergey, George D Harris, Gerard J Malnar, Sean M Harper, R Stephen Griffith, Aaron J Bonham, Diane M Harper
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96277 (2014)
OBJECTIVE:Safety net health care centers in the US serve vulnerable and underinsured females. The primary aim of this work was to determine if HPV4 dosing compliance differs between females who receive doses at rural vs. urban core safety net health
Externí odkaz:
https://doaj.org/article/668d3e1f42d045dbbeca1b09d455a2ad
Autor:
Inge Verdenius, Diane M Harper, George D Harris, R Stephen Griffith, Jeffrey Wall, Laura K Hempstead, Gerard J Malnar, Ruud L M Bekkers
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71295 (2013)
BackgroundHPV4 is approved as a series of three timed doses expected to result in efficacy against specific HPV infections. Completion rates in the US are quite low at the same time the structure of health care delivery is changing. The aim of this s
Externí odkaz:
https://doaj.org/article/c766752e8c6645eb9534f9ef3ba310d4
Autor:
Diane M Harper, Inge Verdenius, Felicia Ratnaraj, Anne M Arey, Beth Rosemergey, Gerard J Malnar, Jeffrey Wall
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e77961 (2013)
PURPOSE: HPV4 is the most expensive vaccine requiring three appropriately timed doses to provide maximal efficacy against two oncogenic HPV types. The primary purpose of this study is to quantify the use of HPV4 vaccine in a safety net health care sy
Externí odkaz:
https://doaj.org/article/a560d04fc91b4c189867288bad8dda6e
Autor:
Nicole Johnson, Saladin Cooper, Gerard J. Malnar, Jennifer L. Hunter, Sarah Smith Hostetter, David L. Howard
Publikováno v:
Maternal and child health journal. 19(7)
To assess the understanding of the term 'Pap smear' among women across the entire adult lifespan after recent changes to the guidelines on cervical cancer screening. Women attending the Obstetrics and Gynecology clinic at a large safety net teaching
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99d39d46ef7c88e9f79a187063f9484
https://pubmed.ncbi.nlm.nih.gov/25630404
https://pubmed.ncbi.nlm.nih.gov/25630404
Autor:
Mitchell J. Bartley, Jennifer A. Groner, Sean M. Harper, Angela L. Barnett, George D. Harris, Beth Rosemergey, Aaron J. Bonham, Anne M. Arey, Britney M. Else, Diane M. Harper, Inge Verdenius, Christopher A. Paynter, Gerard J. Malnar, Jeffrey Wall
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e103172 (2014)
PLoS ONE
PLoS ONE
Objectives Obesity adversely inhibits antibody response to vaccination. Three doses of HPV4 may or may not provide adequate long term protection against HPV 16/18 in obese females. The aim of this study was to determine whether adherence to HPV4 vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda93cbb79bc775a3b724dd46a2c6bd0
http://europepmc.org/articles/PMC4116139?pdf=render
http://europepmc.org/articles/PMC4116139?pdf=render
Urban and rural safety net health care system clinics: no disparity in HPV4 vaccine completion rates
Autor:
Christopher A. Paynter, Kelly Jo Sandri, Gerard J. Malnar, Beth Rosemergey, Inge Verdenius, Mitchell J. Bartley, Aaron J. Bonham, George D. Harris, Sean M. Harper, R. Stephen Griffith, Britney M. Else, Diane M. Harper
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96277 (2014)
PLoS ONE
PLoS ONE
Objective: Safety net health care centers in the US serve vulnerable and underinsured females. The primary aim of this work was to determine if HPV4 dosing compliance differs between females who receive doses at rural vs. urban core safety net health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76a4d985b8e25dde7d2ac0c05181f59
http://europepmc.org/articles/PMC4015932?pdf=render
http://europepmc.org/articles/PMC4015932?pdf=render
Autor:
Angela L. Barnett, George D. Harris, Beth Rosemergey, Jeffrey Wall, Gerard J. Malnar, Anne M. Arey, Diane M. Harper, Inge Verdenius
Publikováno v:
Preventive medicine. 61
Objective Economic incentives can positively influence social determinants to improve the health care of the uninsured and underserved populations. The aim of this study was to determine if free HPV4 vaccine would lead to on-time series completion in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b673bf885d06e7c1649eccaba3e2fc6b
https://pubmed.ncbi.nlm.nih.gov/25657170
https://pubmed.ncbi.nlm.nih.gov/25657170
Autor:
Laura K. Hempstead, Ruud L.M. Bekkers, Jeffrey Wall, R. Stephen Griffith, Inge Verdenius, George D. Harris, Gerard J. Malnar, Diane M. Harper
Publikováno v:
PLoS ONE
PLoS One, 8, 8
PLoS One, 8
PLoS ONE, Vol 8, Iss 8, p e71295 (2013)
PLoS One, 8, 8
PLoS One, 8
PLoS ONE, Vol 8, Iss 8, p e71295 (2013)
Contains fulltext : 183582.PDF (Publisher’s version ) (Open Access) BACKGROUND: HPV4 is approved as a series of three timed doses expected to result in efficacy against specific HPV infections. Completion rates in the US are quite low at the same t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff4e12eb389aa695255d2492ff11e890
https://doi.org/10.1371/journal.pone.0071295
https://doi.org/10.1371/journal.pone.0071295